Clinical Significance of the XXXX to Albumin Ratio for Survival After Surgery for @entity14 .

@entity1 @entity18880 @entity32 @entity5 @entity157 @entity14 @entity16565 @entity1349 @entity1851
OBJECTIVE: This study was designed to estimate the clinical significance of the @entity16565 for prediction of postoperative survival in @entity1 with @entity14 ( @entity14 ). BACKGROUND: The @entity18880 ( @entity18880 ), calculated from the serum levels of @entity1851 and albumin, is well known to be a valuable @entity32 -based prognostic system for several types of @entity5 . A recent study has demonstrated that the @entity16565 is also useful for prediction of treatment outcome in @entity1 with @entity157 . METHODS: Uni- and multivariate analyses using the Cox proportional hazards model were performed to detect the clinical characteristics that were most closely associated with @entity1349 ( @entity1349 ). All recommended cutoff values were defined using receiver operating characteristic curve analyses. Kaplan-Meier analysis was used to compare @entity1349 curves between the two groups. RESULTS: A total of 627 @entity1 who had undergone elective @entity14 surgery were enrolled. Multivariate analysis using the results of univariate analyses demonstrated that @entity16565 (>0.038/ <=0.038) was associated with @entity1349 (hazard ratio 2.596; 95  % confidence interval 1.603-4.204; P  <  0.001) along with pathological differentiation (others/well or moderately), carcinoembryonic antigen level (>8.7/ <=8.7, ng/ml), stage (III, IV/0, I, II), neutrophil to lymphocyte ratio (NLR) (>2.9/ <=2.9), and @entity18880 (2/0, 1). Kaplan-Meier analysis and log rank test demonstrated a significant difference in @entity1349 curves between @entity1 with low @entity16565 ( <=0.038) and those with high @entity16565 (>0.038; P  <  0.001). CONCLUSIONS: @entity16565 is as useful for predicting the postoperative survival of @entity1 with @entity14 as previously reported @entity32 -based prognostic systems, such as @entity18880 and NLR.
